Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 15 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 10815455

    Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1

    Vaximm AG · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  2. US 10806750

    RNAi therapy for hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  3. US 10806716

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  4. US 10799567

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  5. US 10780067

    Endoxifen for local transdermal therapy to the breast

    Northwestern University · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  6. US 10780093

    Methods of treating brain tumors using combination therapy

    Agios Pharmaceuticals, Inc. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  7. US 10774122

    ERG targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  8. US 10772913

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  9. US 10765745

    Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  10. US 10759905

    Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  11. US 10744116

    Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas

    The Regents of the University of California · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  12. US 10722487

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  13. US 10722523

    Chemoimmunotherapy for epithelial cancer

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  14. US 10722537

    Activation of resident memory T cells for cancer immunotherapy

    Regents of the University of Minnesota · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  15. US 10711312

    Methods for immunotherapy-based treatment and assessment of cancer

    The Regents of the University of California · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  16. US 10703797

    Gene therapy vectors for treatment of Danon disease

    Rocket Pharmaceuticals, Ltd. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  17. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  18. US 10695352

    Combination therapy for treating malignancies

    Agios Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  19. US 10695372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  20. US 10688203

    Methods of performing brachytherapy

    The Board of Regents of the University of Texas System · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  21. US 10683272

    Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy

    Northwestern University · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  22. US 10682388

    Targeting of PELP1 in cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  23. US 10676530

    Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  24. US 10675271

    Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

    Monopar Therapeutics Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.